Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
Restricted accessResearch articleFirst published online October, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
SiembidaEJ, Loomans-KroppHA, Tami-MauryI, et al.Barriers and facilitators to adolescent and young adult cancer trial enrollment: NCORP site perspectives. JNCI Cancer Spectrum, 2021; 5(3):pkab027; doi: 10.1093/jncics/pkab027
2.
DavisLE, JanewayKA, WeissAR, et al.Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer, 2017; 123(18):3434–3440; doi: 10.1002/cncr.30757
3.
SankaranH, FinniganSR, McShaneLM, et al.Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network. Cancer, 2022; 128(21):3843–3849; doi: 10.1002/cncr.34402
4.
AvutuV, WeissAR, ReedDR, et al.Identified enrollment challenges of adolescent and young adult patients on the nonchemotherapy arm of children's oncology group study ARST1321. J Adolesc Young Adult Oncol, 2022; 11(3):328–332; doi: 10.1089/jayao.2021.0103
5.
BerkmanAM, MurphyKM, SiembidaEJ, et al.Inclusion of patient-reported outcomes in adolescent and young adult phase III therapeutic trials: An analysis of cancer clinical trials registered on ClinicalTrials.gov. Value Health, 2021; 24(12):1820–1827; doi: 10.1016/j.jval.2021.06.012
